Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT02474641

Hypofractionation With Simultaneous Integrated Boost vs. Standard Fractionation in Early Breast Cancer

Adjuvant Radiotherapy After Breast-conserving Surgery in Early Breast Cancer: Hypofractionation With Simultaneous Integrated Boost vs. Standard Fractionation

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
2,324 (actual)
Sponsor
University Hospital Schleswig-Holstein · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

Hypofractionation with simultaneous integrated boost has been investigated in a few trials and appears to be safe and feasible. Investigators initiated this multicenter two-armed phase III prospective trial to analyse the non-inferiority of hypofractionation with simultaneous integrated boost in patients with early breast cancer in comparison to standard fractionation.

Detailed description

Control Arm: Conventionaly fractionated radiotherapy of the breast 28 × 1.8 Gy = 50.4 Gy followed by a tumor bed boost sequentially 5 to 8 × 2.0 Gy = 10.0 Gy to 16.0 Gy, total dose 60.4 Gy to 66.4 Gy. or Conventionaly fractionated radiotherapy of the breast 28 × 1.8 Gy = 50.4 Gy with simultaneous integrated boost to the tumor bed, total dose 28 × 0.3 Gy or 0.45 Gy= 8.4 Gy or 12,6 Gy, total dose 58,8 Gy to 63.0 Gy. or Hypofractionated radiotherapy of the breast 16 × 2.66 Gy = 42.56 Gy followed by a tumor bed boost sequentially 5 to 8 × 2.0 Gy = 10.0 Gy to 16.0 Gy, total dose 52.56 Gy to 58.56 Gy. Experimental Arm: Hypofractionated radiotherapy of the breast 16 × 2.50 Gy with simultaneous integrated boost to the tumor bed, total dose within the boost volume 16 × 3.00 Gy.

Conditions

Interventions

TypeNameDescription
RADIATIONStandard RadiationConventionally fractionated radiotherapy of the breast followed by a tumor bed boost sequentially or Conventionally fractionated radiotherapy of the breast with simultaneous integrated boost to the tumor bed or Hypofractionated radiotherapy of the breast followed by a tumor bed boost sequentially
RADIATIONHypofractionation with SIBHypofractionated radiotherapy of the breast with simultaneous integrated boost to the tumor bed

Timeline

Start date
2015-06-16
Primary completion
2019-01-08
Completion
2028-03-31
First posted
2015-06-18
Last updated
2024-03-21

Locations

88 sites across 1 country: Germany

Source: ClinicalTrials.gov record NCT02474641. Inclusion in this directory is not an endorsement.